1. |
中国抗癫痫协会. 临床诊疗指南: 癫痫病分册. 北京: 人民卫生出版社, 2023.
|
2. |
王珍珍. 长程视频脑电图对癫痫的诊断价值探究. 中外女性健康研究, 2023(6): 222-3,34.
|
3. |
孙丰森, 张世鹏, 许述. 4种抗癫痫新药的研究和开发. 国际药学研究杂志, 2018, 45(11): 845-51.
|
4. |
2014年《药学与临床研究》总目录. 药学与临床研究, 2014, 22 (6): 581-584.
|
5. |
2023年《药学与临床研究》总目录. 药学与临床研究, 2023, 31(6): 577-580.
|
6. |
裴紫娟, 王博文, 笱玉兰. 吡仑帕奈单药治疗成人局灶性癫痫的临床疗效及安全性评价. 实用药物与临床, 2023, 26(2): 132-5.
|
7. |
石小莉, 李丽霞, 卢燕婷, 等. 吡仑帕奈添加治疗≥12岁局灶性癫痫患者的临床观察. 中华神经医学杂志, 2024, 23(1): 48-54.
|
8. |
姜振浩, 李蕊, 渠蕊, 等. 吡仑帕奈添加治疗儿童局灶性癫痫的疗效及影响因素. 实用药物与临床, 2023, 26(9): 816-820.
|
9. |
Li Y, Zeng Y, Mu J, et al. The efficacy and safety of adjunctive perampanel for the treatment of refractory focal-onset seizures in patients with epilepsy: a meta-analysis. Epilepsia Open, 2022, 7(2): 271-279.
|
10. |
Mai J, Li H, He Y, et al. Efficacy and safety of perampanel as the first add-on therapy for children with epilepsy: a real-world multicenter prospective observational study. Seizure, 2024, 117: 44-49.
|
11. |
Chu SJ, Li Y, Tang JH. Effectiveness and tolerability of adjunctive perampanel in pediatric patients (aged 4-12 years) with refractory epilepsy: an observational study. Medicine (Baltimore), 2022, 101(45): e31408.
|
12. |
Lignore C, Izzi F, Manfredi N, et al. Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: a retrospective single center study. Epilepsy Behav, 2018, 80: 173-176.
|
13. |
Yi JQ, Huang S, Wu MJ, et al. Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy. Front Pharmacol, 2023, 14: 1189058.
|
14. |
Zhou R, Qu R, Liu M, et al. Perampanel and lacosamide monotherapy in pediatric patients with newly diagnosed focal epilepsy: a prospective study evaluating efficacy, tolerability, and behavior. Epilepsy Behav, 2023, 146: 109353.
|
15. |
杨黎, 董宪喆, 齐晓涟, 等. 左乙拉西坦在临床应用中疗效与安全性的研究进展. 中国新药杂志, 2021, 30(7): 607-610.
|
16. |
Yu T, Teng ZT, Liu XY, et al. Effectiveness of perampanel in the treatment of pediatric patients with focal epilepsy and ESES: a single-center retrospective study. Front Pharmacol, 2022, 13: 1026836.
|
17. |
张忠胜, 孔学健. 吡仑帕奈与奥卡西平单药治疗成人局灶性癫痫的有效性和安全性研究. 癫痫杂志, 2024, 10(1): 39-43.
|
18. |
麦子荆. 吡仑帕奈治疗儿童癫痫的有效性和安全性分析. 郑州大学, 硕士学位论文, 2022.
|
19. |
柯晓生. 吡仑帕奈在2~12岁中国汉族儿童药物难治性癫痫添加治疗中的疗效和安全性研究. 福建医科大学, 硕士学位论文, 2021.
|
20. |
Lim SC, Lee WG, Kim DW, et al. Safety and effectiveness of perampanel monotherapy after adjunctive therapy through retention rate in subjects with focal-onset seizures with or without focal to bilateral tonic-clonic seizures: a multicenter retrospective study in Korea. Epilepsy Behav, 2023, 145: 109291.
|
21. |
Bai X, Dong Q, Zhao L, et al. microRNA-106b-containing extracellular vesicles affect autophagy of neurons by regulating CDKN2B in Parkinson's disease. Neurosci Lett, 2021, 760: 136094.
|
22. |
Kim KW, Kim K, Kim HJ, et al. Posttranscriptional modulation of KCNQ2 gene expression by the miR-106b microRNA family. Proc Natl Acad Sci USA, 2021, 118(47): e2110200118.
|
23. |
An N, Zhao W, Liu Y, et al. Elevated serum miR-106b and miR-146a in patients with focal and generalized epilepsy. Epilepsy Res, 2016, 127: 311-316.
|
24. |
ZhaoJQ, Sang Y, Zhang Y, et al. Efficacy of levetiracetam combined with sodium valproate on pediatric epilepsy and its effect on serum miR-106b in children. Exp Ther Med, 2019, 18(6): 4436-4442.
|